PRENATAL AND LACTATION SUPPLEMENTS TO ENHANCE CENTRAL NERVOUS SYSTEM DEVELOPMENT OF OFFSPRING

Disclosed are prenatal and lactation supplements for pregnant women and lactating women, which include a combination of RRR-alpha-tocopherol, docosahexaenoic acid (DHA), trans-lutein, phospholipids, and at least one nuclear receptor activating ligand other than RRR-alpha-tocopherol, DHA, and trans-l...

Full description

Saved in:
Bibliographic Details
Main Authors SHERRY, CHRISTINA, LAI, CHRON-SI, KUCHAN, MATTHEW, GONZALEZ, MARIA RAMIREZ, SANTOS, ANGELA, DELGADO, ELENA, OLIVEROS, KATZ, GARY, BLOCH, TAMA
Format Patent
LanguageEnglish
Published 29.10.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are prenatal and lactation supplements for pregnant women and lactating women, which include a combination of RRR-alpha-tocopherol, docosahexaenoic acid (DHA), trans-lutein, phospholipids, and at least one nuclear receptor activating ligand other than RRR-alpha-tocopherol, DHA, and trans-lutein. The supplements may enhance central nervous system development in a fetus or breast-feeding newborn infant.
Bibliography:Application Number: SG20151107219W